{"canonical":"https://abierto.us/vendors/scantox-neuro-gmbh-ed41xcpbepu1","key":"ED41XCPBEPU1","name":"SCANTOX NEURO GMBH","uei":"ED41XCPBEPU1","city":"GRAMBACH","state":null,"awards":4,"obligated":"21787.48","notices_won":0,"top_agency_name":"National Institutes of Health","top_naics":"325412","cage":"3613N","parent_name":"SCANTOX NEURO GMBH","also_known_as":[],"country":"AUT","actions":9,"first_action":"2024-12-06","last_action":"2026-06-03","breakdowns":{"naics":[{"key":"325412","name":null,"awards":1,"obligated":"21787.50"},{"key":"541380","name":null,"awards":2,"obligated":"0.00"},{"key":"621511","name":null,"awards":1,"obligated":"-0.02"}],"agencies":[{"key":"7529","name":"National Institutes of Health","awards":4,"obligated":"21787.48"}],"award_types":[{"key":"PURCHASE ORDER","name":null,"awards":3,"obligated":"21787.50"},{"key":"DELIVERY ORDER","name":null,"awards":1,"obligated":"-0.02"}],"competition":[{"key":"COMPETED UNDER SAP","name":null,"awards":3,"obligated":"-0.02"},{"key":"NOT COMPETED UNDER SAP","name":null,"awards":1,"obligated":"21787.50"}],"product_service_codes":[{"key":"6505","name":null,"awards":1,"obligated":"21787.50"},{"key":"Q301","name":null,"awards":3,"obligated":"-0.02"}]},"awards_list":[{"award_key":"CONT_AWD_75N95D25P00029_7529_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N95D25P00029_7529_-NONE-_-NONE-/","piid":"75N95D25P00029","parent_piid":null,"award_type":"PURCHASE ORDER","vendor_key":"ED41XCPBEPU1","recipient_name":"SCANTOX NEURO GMBH","recipient_uei":"ED41XCPBEPU1","recipient_cage":"3613N","recipient_city":"GRAMBACH","recipient_state":null,"sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NIA","office_key":"o-75N95D","first_action_date":"2024-12-23","last_action_date":"2024-12-23","actions":1,"obligated":"21787.50","current_total_value":"21787.50","potential_total_value":"21787.50","naics":"325412","psc":"6505","extent_competed":"NOT COMPETED UNDER SAP","set_aside":"NO SET ASIDE USED.","offers_received":1,"description":"REAGENT MATERIALS - HYDROXY CHLOROQUINE SULPHATE AND CHIRAL SEPARATION/PURIFICATION","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_AWD_75N95022P00542_7529_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N95022P00542_7529_-NONE-_-NONE-/","piid":"75N95022P00542","parent_piid":null,"award_type":"PURCHASE ORDER","vendor_key":"ED41XCPBEPU1","recipient_name":"SCANTOX NEURO GMBH","recipient_uei":"ED41XCPBEPU1","recipient_cage":"3613N","recipient_city":"GRAMBACH","recipient_state":null,"sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NIDA","office_key":"o-75N950","first_action_date":"2024-12-06","last_action_date":"2025-05-02","actions":2,"obligated":"0","current_total_value":"249000.00","potential_total_value":"249000.00","naics":"541380","psc":"Q301","extent_competed":"COMPETED UNDER SAP","set_aside":"NO SET ASIDE USED.","offers_received":1,"description":"TOLERABILITY STUDIES OF CANDIDATE AD DRUGS AND EFFICACY OF POLY(L-LYSINE SUCCINYLATED)-HYDROXYCHLOROQUINE (PLS-HCQ) IN A TRANSGENIC AD MOUSE MODEL","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_AWD_75N95023P00617_7529_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N95023P00617_7529_-NONE-_-NONE-/","piid":"75N95023P00617","parent_piid":null,"award_type":"PURCHASE ORDER","vendor_key":"ED41XCPBEPU1","recipient_name":"SCANTOX NEURO GMBH","recipient_uei":"ED41XCPBEPU1","recipient_cage":"3613N","recipient_city":"GRAMBACH","recipient_state":null,"sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NIDA","office_key":"o-75N950","first_action_date":"2024-12-06","last_action_date":"2025-04-30","actions":2,"obligated":"0","current_total_value":"249334.00","potential_total_value":"249334.00","naics":"541380","psc":"Q301","extent_competed":"COMPETED UNDER SAP","set_aside":"NO SET ASIDE USED.","offers_received":1,"description":"PHARMACODYNAMIC AND TOLERABILITY STUDIES OF CANDIDATE AD DRUGS IN A TRANSGENIC AD MOUSE MODEL","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_AWD_75N95022F00001_7529_75N95022D00012_7529","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N95022F00001_7529_75N95022D00012_7529/","piid":"75N95022F00001","parent_piid":"75N95022D00012","award_type":"DELIVERY ORDER","vendor_key":"ED41XCPBEPU1","recipient_name":"SCANTOX NEURO GMBH","recipient_uei":"ED41XCPBEPU1","recipient_cage":"3613N","recipient_city":"GRAMBACH","recipient_state":null,"sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NIDA","office_key":"o-75N950","first_action_date":"2026-06-03","last_action_date":"2026-06-03","actions":1,"obligated":"-0.02","current_total_value":"637999.98","potential_total_value":"637999.98","naics":"621511","psc":"Q301","extent_competed":"COMPETED UNDER SAP","set_aside":null,"offers_received":null,"description":"EXPERIMENTAL VALIDATION OF CANDIDATE ALZHEIMER'S DISEASE TREATMENTS IDENTIFIED BY MULTI-OMICS ANALYSES","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null}],"awards_total":4,"awards_page":1,"won":[],"won_total":0,"solicitations_won":[]}